Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
This novel drug has the potential to treat metabolic abnormalities associated with obesity as well as diseases resulting from it due to its distinct mechanism of action
The peptide's anti-inflammatory effects complement its synaptogenic properties, as chronic neuroinflammation actively disrupts synaptic function and prevents formation of new synapses
Cold chain transportation protects them and the patients who need them
Then add growth-stimulating treatments if additional support is needed
Unlike traditional GLP-1 agonists, which primarily enhance insulin secretion and suppress appetite, Tirzepatide harnesses the additional effects of GIP, further improving metabolic control and promoting weight loss
US$ 29.93
US$ 25.11
US$ 21.86
